标题/作者	年份
Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock, HC Prescott Jama 324 (8), 782-793	2020
Multisystem inflammatory syndrome in US children and adolescents LR Feldstein, EB Rose, SM Horwitz, JP Collins, MM Newhams, MBF Son, ... New England Journal of Medicine 383 (4), 334-346	2020
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 Y Huang, C Yang, X Xu, W Xu, S Liu Acta Pharmacologica Sinica 41 (9), 1141-1149	2020
Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941	2020
Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy G Grasselli, M Greco, A Zanella, G Albano, M Antonelli, G Bellani, ... JAMA internal medicine 180 (10), 1345-1355	2020
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives M Nishiga, DW Wang, Y Han, DB Lewis, JC Wu Nature Reviews Cardiology 17 (9), 543-558	2020
COVID-19 and diabetes mellitus: from pathophysiology to clinical management S Lim, JH Bae, HS Kwon, MA Nauck Nature Reviews Endocrinology 17 (1), 11-30	2021
Covid-19 and kidney transplantation E Akalin, Y Azzi, R Bartash, H Seethamraju, M Parides, V Hemmige, ... New England Journal of Medicine 382 (25), 2475-2477	2020
Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series SF Lax, K Skok, P Zechner, HH Kessler, N Kaufmann, C Koelblinger, ... Annals of internal medicine 173 (5), 350-361	2020
Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA internal medicine 181 (1), 24-31	2021
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 J Magagnoli, S Narendran, F Pereira, TH Cummings, JW Hardin, ... Med 1 (1), 114-127. e3	2020
Immune response, inflammation, and the clinical spectrum of COVID-19 LF García Frontiers in immunology 11, 1441	2020
The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections J Machhi, J Herskovitz, AM Senan, D Dutta, B Nath, MD Oleynikov, ... Journal of Neuroimmune Pharmacology 15, 359-386	2020
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 S Arshad, P Kilgore, ZS Chaudhry, G Jacobsen, DD Wang, K Huitsing, ... International journal of infectious diseases 97, 396-403	2020
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup MK Nadim, LG Forni, RL Mehta, MJ Connor Jr, KD Liu, M Ostermann, ... Nature reviews nephrology 16 (12), 747-764	2020
Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany A Bäuerle, M Teufel, V Musche, B Weismüller, H Kohler, M Hetkamp, ... Journal of Public Health 42 (4), 672-678	2020
How COVID-19 induces cytokine storm with high mortality S Hojyo, M Uchida, K Tanaka, R Hasebe, Y Tanaka, M Murakami, ... Inflammation and regeneration 40, 1-7	2020
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions C Tschöpe, E Ammirati, B Bozkurt, ALP Caforio, LT Cooper, SB Felix, ... Nature Reviews Cardiology 18 (3), 169-193	2021
Depression, anxiety and stress among Indians in times of Covid-19 lockdown U Rehman, MG Shahnawaz, NH Khan, KD Kharshiing, M Khursheed, ... Community mental health journal 57, 42-48	2021
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons SH Nile, A Nile, J Qiu, L Li, X Jia, G Kai Cytokine & growth factor reviews 53, 66-70	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。